SG HealthCare Statistics
Total Valuation
SG HealthCare has a market cap or net worth of KRW 40.73 billion. The enterprise value is 42.35 billion.
Market Cap | 40.73B |
Enterprise Value | 42.35B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SG HealthCare has 10.83 million shares outstanding. The number of shares has increased by 13.93% in one year.
Current Share Class | 10.83M |
Shares Outstanding | 10.83M |
Shares Change (YoY) | +13.93% |
Shares Change (QoQ) | +4.33% |
Owned by Insiders (%) | 31.62% |
Owned by Institutions (%) | 8.40% |
Float | 7.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.29 |
PB Ratio | 1.83 |
P/TBV Ratio | 1.86 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 266.48, with an EV/FCF ratio of -8.11.
EV / Earnings | -12.70 |
EV / Sales | 2.38 |
EV / EBITDA | 266.48 |
EV / EBIT | n/a |
EV / FCF | -8.11 |
Financial Position
The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.30.
Current Ratio | 4.01 |
Quick Ratio | 2.33 |
Debt / Equity | 0.30 |
Debt / EBITDA | 41.50 |
Debt / FCF | -1.26 |
Interest Coverage | -0.49 |
Financial Efficiency
Return on equity (ROE) is -18.49% and return on invested capital (ROIC) is -0.56%.
Return on Equity (ROE) | -18.49% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -0.56% |
Return on Capital Employed (ROCE) | -0.85% |
Revenue Per Employee | 508.58M |
Profits Per Employee | -95.31M |
Employee Count | 35 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -119.39M |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 0.03 |
52-Week Price Change | n/a |
50-Day Moving Average | 3,519.40 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 52.24 |
Average Volume (20 Days) | 320,790 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SG HealthCare had revenue of KRW 17.80 billion and -3.34 billion in losses. Loss per share was -347.73.
Revenue | 17.80B |
Gross Profit | 5.59B |
Operating Income | -226.62M |
Pretax Income | -3.41B |
Net Income | -3.34B |
EBITDA | 158.94M |
EBIT | -226.62M |
Loss Per Share | -347.73 |
Balance Sheet
The company has 5.05 billion in cash and 6.60 billion in debt, giving a net cash position of -1.55 billion or -143.08 per share.
Cash & Cash Equivalents | 5.05B |
Total Debt | 6.60B |
Net Cash | -1.55B |
Net Cash Per Share | -143.08 |
Equity (Book Value) | 22.26B |
Book Value Per Share | 2,064.87 |
Working Capital | 15.37B |
Cash Flow
In the last 12 months, operating cash flow was -547.83 million and capital expenditures -4.68 billion, giving a free cash flow of -5.22 billion.
Operating Cash Flow | -547.83M |
Capital Expenditures | -4.68B |
Free Cash Flow | -5.22B |
FCF Per Share | -482.27 |
Margins
Gross margin is 31.43%, with operating and profit margins of -1.27% and -18.74%.
Gross Margin | 31.43% |
Operating Margin | -1.27% |
Pretax Margin | -19.17% |
Profit Margin | -18.74% |
EBITDA Margin | 0.89% |
EBIT Margin | -1.27% |
FCF Margin | n/a |
Dividends & Yields
SG HealthCare does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.93% |
Shareholder Yield | n/a |
Earnings Yield | -8.19% |
FCF Yield | -12.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.3285691.
Last Split Date | Dec 4, 2024 |
Split Type | Reverse |
Split Ratio | 0.3285691 |
Scores
SG HealthCare has an Altman Z-Score of 2.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.38 |
Piotroski F-Score | 2 |